IP Library Granted Patent US 7,396,643
Granted Patent B2
US 7,396,643 · App. 09/816,763 · Granted Jul 8, 2008

Method for the screening, the detection and/or the quantification of transcriptional factors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,396,643
App. No.
09/816,763
Granted
Jul 8, 2008
Kind
B2
Abstract

The present invention is related to a screening, detection and/or quantification method of one or more transcriptional factor(s) (1) possibly present in a biological sample, said method comprising the steps of: possibly extracting and isolating said transcriptional factor (1) from said biological sample, putting into contact the transcriptional factor (1) with a double-stranded DNA sequence (2) bound to an insoluble solid support (3), and detecting and/or quantifying said fixed transcriptional factor (1), said double-stranded DNA sequence having a specific sequence able to be fixed by the transcriptional factor (1) and being preferably located at a distance of at least about 6.8 nm from the surface of the solid support (3), and said double-stranded DNA sequence being bound to the surface of the insoluble solid support (3) at a concentration of at least 0.01 pmole/cm 2 of solid support surface (3). The present invention is also related to the kit comprising means and media for performing said method.

Claims (28)

1. A screening and/or quantification method of one or more activated transcriptional factors(s) present in a cell or cell lysate, said method comprising the steps of:

(a) binding to an insoluble solid support double-stranded DNA sequence(s) at the concentration of at least 0.01 pmole/cm 2 of said solid support surface, wherein the solid support is an array bearing at least 4 spots/cm 2 of solid support surface, each spot containing double-stranded DNA sequence(s) for the binding of activated transcriptional factor(s), said double-stranded DNA sequence comprising a specific sequence, said specific sequence being able to bind said one or more activated transcriptional factor(s) and said double-stranded DNA sequence being connected to the surface of the solid support by a spacer wherein said spacer is a double-stranded DNA nucleotide sequence of between about 50 and about 250 base pairs, or wherein the spacer comprises a double-stranded DNA nucleotide sequence of between about 50 and about 250 base pairs, and wherein said double-stranded DNA nucleotide sequence of between about 50 and about 250 base pairs is not present in said cell;

(b) putting into contact said one or more activated transcriptional factor(s) with said bound double-stranded DNA sequence(s); and

(c) identifying and/or quantifying a signal specific for the binding of said activated transcriptional factor(s) upon said double-stranded DNA sequence(s).

2. The method according to claim 1 , wherein the transcriptional factor is present in solution at concentration lower than 20 nmolar (nM).

3. The method according to claim 1 , wherein the signal resulting from the binding of the activated transcriptional factor upon the double-stranded DNA sequence is a non-radioactive signal.

4. The method according to claim 1 , wherein the signal resulting from the binding of the activated transcriptional factor upon the double-stranded DNA sequence is obtained through an enzymatic reaction.

5. The method according to claim 1 , wherein said activated transcriptional factors are present in same biological sample.

6. The method according to claim 1 , wherein said activated transcriptional factors are selected from the group consisting of NF-KB, AP-1, CREB, SP-1, C/EBP, GR, HIF-1, Myc, NF-AT, Oct, TBP, CBF-1 and factors listed in table 1.

7. The method according to claim 1 , wherein said one or more activated transcriptional factors are put into contact with said bound double-stranded DNA sequence(s) upon same support or upon same multiwell plate.

8. The method according to claim 1 , wherein the binding of the double-stranded DNA sequence(s) to the solid support is of non-covalent type and includes a binding pair comprising a first member and a second member, said first member being bound to the double-stranded DNA sequence, said second member being bound to the surface of the solid support.

9. The method of claim 8 , wherein said binding pair is biotin/streptavidin.

10. The method according to claim 8 , wherein the binding pair is selected from the group consisting of biotin/streptavidin, hapten/receptor and antigen/antibody binding pair.

11. The method according to claim 1 , wherein the double-stranded DNA sequence(s) are covalently bound to the surface of the insoluble solid support.

12. The method according to claim 1 , wherein the double-stranded DNA sequence comprises repeated specific sequences.

13. The method according to claim 1 , wherein the double-stranded DNA sequences fixed on the support surface contain one or several of the specific DNA sequences presented in the table 1.

14. The method according to claim 1 , comprising the step of identifying at least one characteristic specific of the transcriptional factor activation.

15. The method according to claim 1 , which comprises the steps of screening, quantifying and/or recovering compounds able to bind to said activated transcriptional factor(s) or inhibit the binding of said activated transcriptional factor(s) to the specific sequence upon the double-stranded DNA sequence(s) bound to said solid support.

16. The method according to claim 1 , which further comprises prior to step (b) the step of contacting said cells with a candidate compound which is being evaluated to determine whether it modulates the binding and/or activity of the said activated transcriptional factor(s).

17. The method according to claim 1 , wherein step (c) comprises the step of identifying activated transcriptional factor(s) and/or peptides which are part of the activated transcriptional factor(s) complex.

18. The method according to claim 1 , which comprises the step of adding in the cell lysate an externally added transcriptional factor or a compound which is able to bind to the specific sequence.

19. The method according to claim 1 , wherein step b) comprises putting into contact said one or more activated transcriptional factor(s) in a cell lysate with said bound double-stranded DNA sequence(s).

20. The method of claim 1 , wherein said identifying and/or quantifying said signal is obtained, detected and/or quantified by addition of antibodies specific for the activated transcriptional factor(s).

21. The method of claim 1 , wherein said identifying and/or quantifying said signal is obtained, detected and/or quantified by addition of antibodies specific for compounds involved in the formation of an activation complex comprising said transcriptional factors.

22. A screening and/or quantification method of one or more activated transcriptional factors(s) present in a cell or cell lysate, said method comprising the steps of:

(a) binding to an insoluble solid support double-stranded DNA sequence(s) at the concentration of at least 0.01 pmole/cm 2 of said solid support surface, wherein the solid support is an array bearing at least 4 spots/cm 2 of solid support surface, each spot containing double-stranded DNA sequence(s) for the binding of activated transcriptional factor(s), said double-stranded DNA sequence comprising a specific sequence, said specific sequence being able to bind said one or more activated transcriptional factor(s) and said double-stranded DNA sequence being connected to the surface of the solid support by a spacer wherein said spacer is a double-stranded DNA nucleotide sequence of between about 50 and about 250 base pairs, or wherein the spacer comprises a double-stranded DNA nucleotide sequence of between about 50 and about 250 base pairs, and wherein said double-stranded DNA nucleotide sequence of between about 50 and about 250 base pairs is not present in said cell;

(b) putting into contact said one or more activated transcriptional factor(s) with said bound double-stranded DNA sequence(s); and

(c) identifying and/or quantifying a signal specific for the binding of said activated transcriptional factor(s) upon said double-stranded DNA sequence(s), wherein said activated transcriptional factor is the HIV integrase.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY'S NAME IN THE ASSIGNMENT DOCUMENT, PREVIOUSLY RECORDED ON REE1 NO.; 012200, FRAME NO.,; 0038 Recorded Oct 7, 2003
From: REMACLE, JOSE; RENARD, PATRICIA; ART, MURIEL
To: ADVANCED ARRAY TECHNOLOGY (A.A.T.)
Reel/Frame 014030/0597 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2003
From: ADVANCED ARRAY TECHNOLOGY S.A. (A.A.T.)
To: EPPENDORF ARRAY TECHNOLOGIES S.A. (E.A.T.)
Reel/Frame 013787/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2001
From: REMACLE, JOSE; RENARD, PATRICIA; ART, MURIEL
To: ADVANCED ARRAY TECHNOLOGIES S.A.
Reel/Frame 012200/0038 →